Propranolol Hydrochloride 10 mg Tablet, 100-count — NDC 0591-5554-01 (Billing 00591-5554-01)
by Actavis Pharma, Inc. · 100 TABLET in 1 BOTTLE, PLASTIC
This is a package of 100 tablets of Propranolol Hydrochloride 10 mg Tablet from Actavis Pharma, Inc., no longer marketed (first marketed May 1986), no longer in the FDA NDC Directory; retail pharmacies pay about $0.0466 per tablet (NADAC). It is the main listing for this product, which comes in 4 package sizes.
NDC 00591-5554-01
🏷️ FDA NDC (as labeled)
0591-5554-01
billing pads the labeler segment with a zero
This package
Also priced by: Medicaid pays $0.1941/unit — full pricing hub ↓
Main listing for product 0591-5554 · Also comes in:
1000 tablets 0591-5554-10
83000 tablets 0591-5554-00
99996 tablets 0591-5554-77
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Excluded from the active FDA NDC Directory.
The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through May 2025. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory.
Search the FDA NDC Directory ↗
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
0591-5554-01
Product NDC
0591-5554
11-digit billing NDC
00591555401
NCPDP billing unit
EA — each (per item)
SPL Set ID
ce833d98-3108-4e24-834a-ad9349b75529
DEA schedule
Non-controlled
Marketing category
DRUG FOR FURTHER PROCESSING
Marketing status
Discontinued
FDA listing status
Discontinued by firm (certified through May 2025)
Marketing start
1986-05-13
Dosage form
TABLET
Substance
PROPRANOLOL HYDROCHLORIDE
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
GPI-14
33100040100305
GPI class
Propranolol HCl
GCN Seq No
005123
GCN
20630
HICL code
002101
Ingredient (HICL)
Propranolol Hcl
HIC1 code
J
Therapeutic class — broad (HIC1)
Autonomic Nervous System
HIC2 code
J7
Therapeutic class — intermediate (HIC2)
Antiadrenergics
HIC3 code
J7C
Therapeutic class — specific (HIC3)
Beta-Adrenergic Blocking Agents
AHFS code
12:16.08.04
AHFS class
Non-Sel. Beta-Adrenergic Blocking Agents
FDB label name
PROPRANOLOL 10 MG TABLET
FDB brand name
Propranolol Hcl
Legend status
F — Federal legend — prescription drug or device
Quick answers
- GSN (GCN sequence number): 005123
- GCN: 20630
- GPI-14 (Medi-Span): 33100040100305
- HICL (First Databank): 002101
- AHFS class code: 12:16.08.04
Why two NDCs?
The FDA registers this code as 0591-5554-01 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00591-5554-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
Clinical
Label name PROPRANOLOL 10 MG TABLET Ingredient Propranolol Hcl
📖 What it is MedlinePlus · NLM
Propranolol is used to treat high blood pressure irregular heartbeats pheochromocytoma (tumor on a small gland near the kidneys) certain types of tremor hypertrophic subaortic stenosis (a heart muscle disease angina (chest pain) migraine headaches Propranolol is also used to improve survival after a heart attack. Propranolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure.
Read the full MedlinePlus article ↗📗 Our plain-language guide HelloPharmacist
- It depends on the product. Tablets and solution treat high blood pressure, angina, atrial fibrillation, migraine prevention and essential tremor, and lower death risk after a heart...
- Please don't stop on your own. Stopping suddenly can worsen angina or even trigger a heart attack. If you need to stop, your prescriber will taper the dose over at least a few week...
- Some people feel tired, lightheaded or have a slow heartbeat. Others get vivid dreams, nausea or stomach upset. Call your doctor for wheezing, fainting, swelling, a severe rash or...
- For InnoPran XL and Inderal XL, take it at bedtime, consistently with food or without. Protein-rich food can increase how much propranolol you absorb, so keep your routine steady....
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Propranolol Hydrochloride — tap one for details:
1
Nutrient depletion considerations
Propranolol Hydrochloride may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
💬 Questions about Propranolol Hydrochloride?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per ea | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.047 | $4.66 / 100 tablets |
| Medicaid paysCMS SDUD · 12 mo | $0.1941 | $19.41 / 100 tablets |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per ea) — tap or hover for the price & month
▼ Down 39% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file · file of Sep 30, 2026
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · through Q4 2025
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Per unit | Per pack | Marketing start | Marketing end | Status |
|---|---|---|---|---|---|---|
| 00591-5554-01 You're viewing this Main listing | 100 TABLET in 1 BOTTLE, PLASTIC | $0.0466 / ea | $4.66 | 1986-05-13 | — | Discontinued by firm |
| 00591-5554-10 0591-5554-10 | 1000 TABLET in 1 BOTTLE, PLASTIC | $0.0466 / ea | $46.57 | 1986-05-13 | — | Discontinued by firm |
| 00591-5554-00 0591-5554-00 | 83000 TABLET in 1 BAG | — | — | — | — | Active |
| 00591-5554-77 0591-5554-77 | 99996 TABLET in 1 CONTAINER | — | — | — | — | Active |
You're viewing the smallest of 4 pack sizes for this product.
This pack has the lowest per-ea cost of the 2 priced pack sizes ($0.0466 NADAC).
In Medicaid, this is the most-dispensed pack of this product — about 75% of fills over the last four reported quarters. See all packs ↓
Pack size FAQ
What quantity is in this package?
This is a 100-count package — 100 tablet in 1 bottle, plastic.
How does this package differ from NDC 00591-5554-10?
Both are Propranolol Hydrochloride 10 mg Tablet — the drug itself is identical. This page's package is the 100-count one, while NDC 00591-5554-10 is the 1000 tablets package.
What NDC number is used to bill for this package of Propranolol Hydrochloride 10 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Propranolol Hydrochloride 10 mg 00378-0182-01 | Mylan | 100 tablets | $0.047 | AB | Availability likely | — |
| Propranolol Hydrochloride 10 mg 00603-5482-21 | Par | 100 tablets | $0.047 | AB | Availability likely | — |
| Propranolol Hydrochloride 10 mg 00904-7467-61 | Major | 100 tablets | $0.047 | AB | Availability likely | — |
| Propranolol Hydrochloride 10 mg 50268-0662-15 | AvPAK | 50 tablets | $0.047 | AB | Availability likely | — |
| Propranolol Hydrochloride 10 mg 60687-0587-01 | American | 100 tablets | $0.047 | AB | Availability likely | — |
| Propranolol Hydrochloride 10 mg 60687-0926-01 | American | 100 tablets | $0.047 | AB | Availability likely | — |
| Propranolol Hydrochloride 10 mg 69238-2077-01 | Amneal | 100 tablets | $0.047 | AB | Availability likely | — |
| Propranolol Hydrochloride 10 mg 69292-0530-01 | AMICI | 100 tablets | $0.047 | AB | Availability likely | — |
| Propranolol hydrochloride 10 mg 70756-0094-11 | Lifestar | 100 tablets | $0.047 | AB | Availability likely | — |
| Propranolol Hydrochloride 10 mg 83980-0005-01 | Ipca | 100 tablets | $0.047 | AB | Availability likely | — |
| Propranolol Hydrochloride 10 mgthis 00591-5554-01 | Actavis | 100 tablets | $0.047 | — | Discontinued | — |
| Propranolol Hydrochloride 10 mg 00615-8417-39 | NCS | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 50090-7097-00 | A-S | 40 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 50090-7593-01 | A-S | 100 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 51407-0235-01 | Golden | 100 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 51655-0864-26 | Northwind | 90 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 55154-2144-00 | Cardinal | 10 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 63629-2274-01 | Bryant | 1000 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 63629-2275-01 | Bryant | 100 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 66267-0261-90 | NuCare | 90 tablets | — | — | FDA listed | — |
| Propranolol Hydrochloride 10 mg 67046-0211-03 | Coupler | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 68071-2710-09 | NuCare | 90 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 68788-4131-01 | Preferred | 100 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 68788-7860-03 | Preferred | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 68788-8604-03 | Preferred | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 70518-3102-00 | REMEDYREPACK | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 70518-3281-00 | REMEDYREPACK | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 70518-4471-00 | REMEDYREPACK | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 71205-0446-30 | Proficient | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 71335-0554-01 | Bryant | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 71335-1994-01 | Bryant | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 71335-2372-01 | Bryant | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 71335-3117-01 | Bryant | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 72162-1175-00 | Bryant | 1000 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 72189-0074-30 | DIRECT | 30 tablets | — | — | FDA listed | — |
| Propranolol Hydrochloride 10 mg 72189-0322-30 | Direct | 30 tablets | — | AB | FDA listed | — |
| Propranolol HCL 10 mg 72189-0672-60 | Direct_Rx | 60 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 72789-0495-90 | PD-Rx | 90 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 76420-0383-00 | Asclemed | 1000 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 80425-0463-01 | Advanced | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 80425-0464-01 | Advanced | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 80425-0583-01 | Advanced | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 82804-0258-30 | Proficient | 30 tablets | — | AB | FDA listed | — |
| Propranolol Hydrochloride 10 mg 55154-2584-00 | Cardinal | 10 tablets | — | AB | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Sep 3, 2026
- CMS NADAC weekly file · file of Sep 30, 2026
Availability & generic status
🏛️
1986
On the market since
May 1986
📍
2026
Currently FDA-listed
40 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available
FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Sep 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerActavis Pharma, Inc.
Labeler code00591
First marketedMay 1986
Product typeDrug For Further Processing
Portfolio324 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
Full FDA label FDA SPL
The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
1.1K
Units reimbursed last 4 qtrs
65.8K
Gross reimbursed last 4 qtrs
$12.8K
Avg / prescription
$11.56
Avg / unit
$0.1941
Latest quarter Q4 2025
110Rx
Medicaid pays / ea
$0.1941
gross reimbursed
vs
NADAC / ea
$0.0466
acquisition cost
=
Spread
+$0.1475
+317% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 486 Rx Managed care · 619 Rx
State Medicaid map
Units reimbursed · per 100k residents
6.4124
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
Medicaid utilization by pack size
Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
Drug total (last 4 qtrs): 905 Rx · 50,168 units · $8,984 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Propranolol Hydrochloride — the ingredient across all brands.
Top reported reactions
Age at onset
Reporter sex
Male · 33%
Female · 67%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
About this NDC listing & data coverage
Listed for further processing / repackaging
No longer marketed (per FDA listing data)
What "drug for further processing" means
FDA lists this package under the "drug for further processing" marketing category: Actavis Pharma, Inc. supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | ✓ Available |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | ✓ Available |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 1000 tablets (00591-5554-10), 83000 tablets (00591-5554-00), 99996 tablets (00591-5554-77). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Actavis Pharma, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.